Mpox remains an international public health emergency, the World Health Organization (WHO) said on Feb 27 (2025). This was after the international health agency decided the epidemic still merits ...
The number of mpox cases in Africa increased leading up to the first mpox declaration of a Public Health Emergency of ...
The World Health Organization (WHO) chief announced on Thursday that the mpox upsurge continues and meets the criteria of a ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...
The two confirmed infected individuals have symptoms such as rash, fever, and headache, as well as pain in the body and ...
Tanzania has confirmed its first two cases of mpox, the health ministry said Monday, the first time the virus has been ...
The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...
The patient, a 29-year-old woman who lives in the metropolitan region of São Paulo, had contact with a relative who had been ...
A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results